Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: Possible implications for lymphocyte traffic and functional recovery

Clinical and Experimental Immunology

Volumn 116, Issue 2, 1999, Pages 307-315

  Sousa, A E ^a   Chaves, A F ^a   Doroana, M ^b   Antunes, F ^b   Victorino, Rui M M ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Anti retroviral therapy; CD40L; Fas; HIV 1 infection; OX40

Indexed keywords

ANTIRETROVIRUS AGENT; CD40 ANTIGEN; FAS ANTIGEN; LAMIVUDINE; NELFINAVIR; STAVUDINE; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL KINETICS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIGENS, CD27; ANTIGENS, CD95; CD4 LYMPHOCYTE COUNT; CD40 LIGAND; CELL MOVEMENT; DRUG THERAPY, COMBINATION; FEMALE; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES;

EID: 0032894849     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00872.x     Document Type: Article

References (47)

1. 1 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-6.
2. 2 Autran B, Carcelain G, Li TS et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Sci 1997; 277:112-6.
3. 3 Connors M, Kovacs JA, Krevat S et al. HIV infection induces changes in CD4+ T cell phenotype and depletions within the CD4+ T cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997; 3:533-40.
4. 4 Pakker NG, Notermans DW, Boer RJ et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Med 1998; 4:208-14.
5. 5 Fleury S, Boer RJ, Rizzardi GP et al. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nature Med 1998; 4:794-801.
6. 6 Gorochov G, Neumann AU, Kereveur A et al. Perturbation of CD4+ and CD8+ T cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nature Med 1998; 4:215-21.
7. 7 Roederer M. Getting to the HAART of T cell dynamics. Nature Med 1998; 4:145-6.
8. 8 Wolthers KC, Sehuitemaker H, Miedema F, Rapid CD4+ T cell turnover in HIV-1 infection: a paradigm revisited. Immunol Today 1998; 19:44-48.
9. 9 Rosenberg JY, Anderson AO, Pabst R. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol Today 1998; 19:10-17.
10. 10 Cohen OJ, Kinter A, Fauci AS. Host factors in the pathogenesis of HIV disease. Immunol Rev 1997; 159:31-48.
11. 11 Bentwich Z, Kalinkovich A, Weisman Z, Grossman Z. Immune activation in the context of HIV infection. Clin Exp Immunol 1998; 111:1-2.
12. 12 Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoisier M, Goujard C, Debord T, Montagnier L. Programmed cell death in peripheral lymphocytes from HIV-infected persons: the increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156:3509-20.
13. 13 Liu Z, Cumberland WG, Hultin LF, Prince HE, Detels R, Giorgi JV, Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovir 1997; 16:83-92.
14. 14 Jaleco A, Covas MJ, Victorino RMM. Analysis of lymphocyte cell death and apoptosis in HIV2 infected patients. Clin Exp Immunol 1994; 18:185-9.
15. + T cell subsets in HIV2 compared with HIV1 infection. AIDS 1994; 8:1663-8.
16. 16 Gougeon M-L, Lecoeur H, Boudet V et al. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol 1997; 158:2964-76.
17. 17 Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334:1717-25.
18. 18 Nagata S, Golstein ML. The Fas death factor. Sci 1995; 267:1449-56.
19. 19 Katsikis PD, Wunderlich ES, Smith C, Herzenberg LA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181:2029-36.
20. 20 Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ. gp39 -CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994; 180:157-63.
21. 21 Stuber E, Strober W. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med 1996; 183:979-89.
22. 22 Blotta MH, Marshall JD, DeKruyff RH, Umetsu DT. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J Immunol 1996; 156:3133-40.
23. 23 Flores-Romo L, Bjork P, Ouvert V, Van Kooten C, Saeland S, Banchereau J. CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med 1997; 185:341-9.
24. 24 Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespess G. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997; 159:3838-48.
25. 25 Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, Imamura S, Uchiyama T. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 1996; 183:2185-95.
26. 26 Yellin MJ, Brett J, Baum D, Malsushima A, Szabolcs M, Stern D, Chess L. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995; 182:1857-64.
27. 27 Weinberg AD, Bourdette DN, Sullivan TJ et al. Selective depletion of myclin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nature Med 1996; 2:183-9.
28. 28 Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta S. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97:2063-73.
29. 29 Tittle TV, Weinberg AD, Steinkeler CN, Maziarz RT. Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood 1997; 89:4652-8.
30. 30 Larsen CP, Pearson TC. The CD40 pathway in allograft rejection, acceptance and tolerance. Cur Opin Immunol 1997; 9:641-7.
31. 31 Datta SK, Kalled SL. CD40 CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997; 40:1735-45.
32. 32 Green K, Noelle RJ, Green WR. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS. Virology 1998; 241: 260-8.
33. 33 Shearer GM. Natural resistance to parental T-lymphocyte-induced immunosuppression in F hybrid mice: implications for acquired immune deficiency syndrome (AIDS). Immunol Rev 1983; 73:115-26.
34. 34 Pinto LA, Dalgleish AG, Sumar N, Poulton TA. Panel of anti-gp120 monoclonal antibodies reacts wilh same nuclear proteins in uninfected cells as those recognised by autoantibodies from patients with systemic lupus erythematosus. AIDS Res Hum Retrovir 1994; 10:823-8.
35. 35 Moses AV, Williams SE, Strussenberg JG, Heneveld ML, Ruhl RA, Bakke GC, Nelson JA. HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. Nature Med 1997; 3:1242-9.
36. 36 Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995; 92:4342-6.
37. 37 Morris L, Binley JM, Clas BA et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998; 188:233-45.
38. 38 Piketty C, Castiel P, Belec T. et al. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998; 12:745-50.
39. 39 Silvestri G, Munoz-Calleja C, Bagnarelli P, Piedionte G, Clementi M, Montroni M. Early increase of CD4+CD45RA+ and CD4+CD95 cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clin Exp Immunol 1998; 111:3-11.
40. 40 Badley AD, Dockrell DH, Algeciras A et al. In vivo analysis of Fas/ PasL interactions in HIV-infected patients. J Clin Invest 1998; 102:79-87.
41. 41 Gandhi RT, Chen BK, Straus SE, Dale JK, Lenardo MJ, Baltimore D. HIV-1 directly kills CD4+ T cells by a Fas independent mechanism. J Exp Med 1998; 187:1113-22.
42. 42 Kaplan D, Sieg S. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J Virol 1998; 72:6279-82.
43. 43 Noble A, Pestano GA, Cantor II. Suppression of immune responses by CD8 cells. I Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells. J Immunol 1998; 159:559-65.
44. 44 Suzuki I. Fink PJ. Maximal proliferation of cytotoxic T lymphocytes requires reverse signalling through Fas ligand. J Exp Med 1998; 187:123-8.
45. + T cell subset. Clin Exp Immunol 1998; 112:294-302.
46. 46 Sousa AE, Chaves AF, Doroana M, Antunes F, Victorino RMM. Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV 1 infection. J Immunol 1999; 162: (in press).
47. 47 Rosok BI, Boetad L, Voltersik P, Berknes R, Olofsson J. Asjo B, Brinchmann JE. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection. AIDS 1996; 10:F35-F38.